A single-dose live attenuated chimeric vaccine candidate against Zika virus
Abstract The mosquito-borne Zika virus is an emerging pathogen from the Flavivirus genus for which there are no approved antivirals or vaccines. Using the clinically validated PDK-53 dengue virus vaccine strain as a backbone, we created a chimeric dengue/Zika virus, VacDZ, as a live attenuated vacci...
Guardado en:
Autores principales: | Wei-Xin Chin, Regina Ching Hua Lee, Parveen Kaur, Tian Sheng Lew, Thinesshwary Yogarajah, Hao Yuin Kong, Zi-Yun Teo, Cyrill Kafi Salim, Rong-Rong Zhang, Xiao-Feng Li, Sylvie Alonso, Cheng-Feng Qin, Justin Jang Hann Chu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96aefe18a1c54f6fb1c868ba72e76b1d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
por: Xiao-Feng Li, et al.
Publicado: (2018) -
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
por: Qi Chen, et al.
Publicado: (2018) -
Erratum for Chen et al., “Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate”
por: Qi Chen, et al.
Publicado: (2019) -
A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice
por: Jovin J. Y. Choo, et al.
Publicado: (2021) -
A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission
por: Awadalkareem Adam, et al.
Publicado: (2021)